Safety and Effectiveness of Orbera365™ Intragastric Balloon System

Not yet recruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

December 31, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Obesity
Interventions
DEVICE

Intragastric Balloon

The Orbera365™ IGB System is to be used in conjunction with a long-term supervised diet and behavior modification program designed to increase the possibility of long-term weight loss maintenance. The IGB is placed in the stomach and filled with sterile saline, causing it to expand into a spherical shape. The filled IGB is designed to occupy space and move freely within the stomach, potentially altering appetite and satiety to achieve weight loss.

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY

NCT07062094 - Safety and Effectiveness of Orbera365™ Intragastric Balloon System | Biotech Hunter | Biotech Hunter